AC vs AT 0 to 3 Positive Nodes

[Barbara2]

Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North American Breast Cancer Intergroup Trial E 2197

http://jco.ascopubs.org/cgi/content/abstract/JCO.2008.16.7841v1